AI generated summary of Pubmed citation/abstract with PMID 38091231

https://pubmed.ncbi.nlm.nih.gov/38091231

This study of 2747 MDS and 182 CMML patients in Japan found that most were over 65 years old, and the overall survival rates at 5 years were 32.3% for MDS and 15.0% for CMML. Azacitidine was the most common treatment for MDS, with lower survival rates in higher-risk patients.